Sun Pharma up 2% as arm gets relief by US court in patent infringement case

On a year-to-date (YTD) basis, Sun Pharma stock has underperformed the Nifty Pharma index by declining around 28 per cent.

On a year-to-date (YTD) basis, Sun Pharma stock has underperformed the Nifty Pharma index by declining around 28 per cent. http://bit.ly/2AgmUME December 26, 2018 at 06:58PM

Comments

Popular posts from this blog